antenatal hospitalization (OR 4.67, 95% CI 2.88-7.57), hypertensive disordersincluding preeclampsia (OR 5.62, 95% CI 2.60-12.15) and a substantial increasein length of hospital stay. Sickle cell disease was associated with an increasedodds of antenatal hospitalization (OR 5.56 95% CI 5.08-6.09), hypertensivedisorders including preeclampsia (OR 1.78, 95% CI 1.48-2.14), and IUGR (OR2.91, 95% CI 2.16-3.93), with a modest increase in length of hospital stay.CONCLUSION: Women with systemic sclerosis, primary pulmonaryhypertension, and sickle cell disease have significantly increased rates ofadverse pregnancy outcomes, requiring extensive preconceptional counselingabout the risks of pregnancy. LEVEL OF EVIDENCE: II.Acta Obstet Gynecol Scand. <strong>2008</strong>;87(2):222-5.Sublingual nitroglycerin seems to be effective in the management ofretained placenta.Ekerhovd E, Bullarbo M.Department of Obstetrics and Gynecology, Sahlgrenska University Hospital,Gothenburg, Sweden. erling.ekerhovd@obgyn.gu.seBACKGROUND: A common approach in the management of retained placenta isadministration of oxytocin followed by controlled cord traction. Previously it hasalso been demonstrated that intravenously administered nitroglycerin facilitatesmanual extraction of retained placenta. The purpose of the present trial was toexamine the success rate and safety of sequential administration of intravenousoxytocin in combination with sublingual nitroglycerin for the delivery of retainedplacenta. METHODS: The report is a chart review of 24 women with retainedplacenta despite intravenously administered oxytocin. The women were givensublingual nitroglycerin (1 mg) to promote detachment of the placenta. Some 5min after resorption of the tablets, controlled cord traction was carried out for amaximum of 5 min. In addition, changes in blood pressure following treatmentwith nitroglycerin and total blood loss during delivery were registered. RESULTS:Twenty-one of the women delivered the placenta successfully followingsublingual administration of nitroglycerin. The procedure failed in 3 women andoperative manual removal under regional or general anesthesia was undertaken.No complications due to nitroglycerin were registered. CONCLUSIONS:Sequential administration of oxytocin and nitroglycerin seems to be an effectiveand safe procedure in the management of retained placenta. However, largerstudies are needed to confirm the encouraging results of the present trial.Am J Obstet Gynecol. <strong>2008</strong> Mar;198(3):283.e1-8. Epub <strong>2008</strong> Jan 14.Postpartum dexamethasone for women with hemolysis, elevated liverenzymes, and low platelets (HELLP) syndrome: a double-blind, placebocontrolled,randomized clinical trial.Katz L, de Amorim MM, Figueiroa JN, Pinto e Silva JL.Department of Obstetrics, Professor Fernando Figueira Institute for Maternal andChild Health Care, Recife, Pernambuco, Brazil. katzleila@yahoo.com.brOBJECTIVE: The purpose of this study was to determine the effectiveness ofpostpartum dexamethasone in patients with hemolysis, elevated liver enzymes,
and low platelets (HELLP) syndrome. STUDY DESIGN: A prospective,randomized, double-blind trial was conducted in which 105 women with HELLPsyndrome were enrolled and assigned randomly to treatment or placebo groupsfollowing delivery. Duration of hospital stay, maternal morbidity, and laboratoryand clinical parameters were evaluated. RESULTS: There was no difference inmaternal morbidity or mortality between the 2 groups. There was also nodifference in duration of hospitalization and the need for rescue scheme or theuse of blood products between groups. Linear model adjustments showed nosignificant difference between groups with respect to the pattern of platelet countrecovery, aspartate aminotransferase, lactate dehydrogenase, hemoglobin, ordiuresis. CONCLUSION: These findings do not support the use ofdexamethasone in the puerperium for recovery of patients with HELLPsyndrome.Am J Obstet Gynecol. <strong>2008</strong> Apr 5 [Epub ahead of print]Clostridium difficile-associated diarrhea: an emerging threat to pregnantwomen.Rouphael NG, O'Donnell JA, Bhatnagar J, Lewis F, Polgreen PM, Beekmann S,Guarner J, Killgore GE, Coffman B, Campbell J, Zaki SR, McDonald LC.Division of Bacterial Diseases, Centers for Disease Control and Prevention,Atlanta, GA.OBJECTIVE: To estimate if Clostridium difficile-associated disease (CDAD) isincreasing in peripartum women. STUDY DESIGN: Peripartum CDAD wasassessed through 1) passive surveillance collecting clinical and pathology dataon severe cases and 2) survey among infectious disease consultants (ICDs) inthe Emerging Infections Network. RESULTS: Ten severe cases were collected;most had associated antibiotic use. Seven women were either admitted to theICU or underwent colectomy. Three infants were stillborn, and 3 women died.The epidemic Clostridium difficile strain was found in 2 cases. Among 798 ICDs,419 (52%) participated in the survey. Thirty-seven respondents (9%) recalled 55cases, mostly in the postpartum period with 21 complications, mainly due torelapse. CONCLUSION: Severe CDAD may be increasing in peripartum women.Clinicians should have a low threshold for testing, be aware of the potential forsevere outcomes, and take steps to reduce both the risk of disease and resultantcomplications.BMJ. <strong>2008</strong> Apr 10 [Epub ahead of print]Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuriain hypertensive pregnant women: systematic review.Côté AM, Brown MA, Lam E, Dadelszen PV, Firoz T, Liston RM, Magee LA.BC Women’s Hospital and Health Centre, Vancouver, BC, Canada.OBJECTIVE: To review the spot protein:creatinine ratio and albumin:creatininaratio as diagnostic tests for significant proteinuria in hypertensive pregnantwomen. DESIGN: Systematic review. DATA SOURCES: Medline and Embase,the Cochrane Library, reference lists, and experts. Review methods Literaturesearch (1980-2007) for articles of the spot protein:creatinine ratio or
- Page 1 and 2: Obstetricia CríticaEduardo Malvino
- Page 3 and 4: gestational age at delivery, Apgar
- Page 5 and 6: Maternal risk factors associated wi
- Page 7 and 8: exclusive categories: 1) bleeding r
- Page 9 and 10: Division of Obstetrics and Gynecolo
- Page 11 and 12: as uncommon as primary synovial sar
- Page 13 and 14: Cardiac Troponin I Elevation After
- Page 15 and 16: significant increase in carbohydrat
- Page 17 and 18: of one per 1500 pregnant women. Cal
- Page 19 and 20: Background: To investigate the rela
- Page 21 and 22: PowerLab hardware unit and Chart v3
- Page 23 and 24: Prophylactic antibiotics for the pr
- Page 25 and 26: years old (n = 23,921). Univariate
- Page 27 and 28: five women uses FDA C, D and X drug
- Page 29 and 30: and complicated. CONCLUSION: Irresp
- Page 31 and 32: clinically effective. Nevertheless,
- Page 33 and 34: Obstetrics and Gynecology Departmen
- Page 35 and 36: Pregnancy-induced severe gestationa
- Page 37 and 38: penicillin or ampicillin, whereas 3
- Page 39 and 40: Abetalipoproteinemia complicating t
- Page 41 and 42: case of acute abdominal pain, abdom
- Page 43 and 44: Callaway LK, Lawlor DA, McIntyre HD
- Page 45: ketoacidosis during induction of la
- Page 49 and 50: Division of Reproduction and Endocr
- Page 51 and 52: simulation center, and to teamwork
- Page 53 and 54: significantly associated with psori
- Page 55 and 56: episiotomy and prophylactic oxytoci
- Page 57 and 58: ecent obesity epidemic has had a pr
- Page 59 and 60: guidelines in 2002. However, the di
- Page 61 and 62: need for intensive neonatal care, h
- Page 63 and 64: mEq/l) metabolic acidosis. Other et
- Page 65 and 66: Acta Obstet Gynecol Scand. 2008;87(
- Page 67 and 68: etrospective review of pregnancies
- Page 69 and 70: Maternal obesity and pregnancy comp
- Page 71 and 72: interval 3.78-5.30) and severe obst
- Page 73 and 74: of GDM. Methods: 1,662 pregnant wom
- Page 75 and 76: Registers. POPULATION: All pregnant
- Page 77 and 78: J Reprod Med. 2008 May;53(5):365-8.
- Page 79 and 80: egarding cervical cancer screening
- Page 81 and 82: College of Surgeons in Ireland, Dub
- Page 83 and 84: maternal morbidity has increased bo
- Page 85 and 86: increased uterine activity was rela
- Page 87 and 88: options.Journal of Perinatology adv
- Page 89 and 90: atio, 1.73; 95% CI, 1.11-2.69). Thi
- Page 91 and 92: discharge at site of perineal repai
- Page 93 and 94: Thirty-one other patients refused t
- Page 95 and 96: Department of Obstetrics and Centre
- Page 97 and 98:
developed any new problems. CONCLUS
- Page 99 and 100:
It seems to be safe to continue bre
- Page 101 and 102:
colonization in a subsequent pregna
- Page 103 and 104:
Crude and adjusted odds ratios were
- Page 105 and 106:
the subsequent development of ESRD.
- Page 107 and 108:
Acta Obstet Gynecol Scand. 2008 Sep
- Page 109 and 110:
OBJECTIVE: To investigate pregnancy
- Page 111 and 112:
OBJECTIVE: To compare the perinatal
- Page 113 and 114:
exceptionally rare. CASE: A 23-year
- Page 115 and 116:
CONCLUSION: This case demonstrates
- Page 117 and 118:
peripartum hysterectomy included ce
- Page 119 and 120:
BMJ. 2008 Sep 8;337:a1397. doi: 10.
- Page 121 and 122:
Lancet. 2008 Sep 17. [Epub ahead of
- Page 123 and 124:
Obstet Gynecol. 2008 Oct;112(4):951
- Page 125 and 126:
Additionally, the effects of distur
- Page 127 and 128:
analyzed. Initial echocardiographic
- Page 129 and 130:
pathologic or anatomically anomalou
- Page 131 and 132:
Eur J Obstet Gynecol Reprod Biol. 2
- Page 133 and 134:
chorioamnionitis; and (3) in contra
- Page 135 and 136:
underlying conditions related to st
- Page 137 and 138:
third trimester of pregnancy.BMJ. 2
- Page 139 and 140:
Texas Health Science Center, Housto
- Page 141 and 142:
preterm birth before 34 weeks (P
- Page 143 and 144:
cases. Most patients (91%) received
- Page 145 and 146:
Ultrasound Obstet Gynecol. 2008 Nov
- Page 147 and 148:
Maggard MA, Yermilov I, Li Z, Magli
- Page 149 and 150:
Clinical and Population Health, Per
- Page 151:
the biologic mechanism is unclear,